BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-19 out of 19 found
  Current Search:  gram: 484, positive: 1303, bacterial: 146     

HTML
61%
PEPTIDE FRAGMENTS OF A {beta}-DEFENSIN DERIVATIVE WITH POTENT BACTERICIDAL ACTIVITY [Article]
PEPTIDE FRAGMENTS OF A -DEFENSIN DERIVATIVE WITH POTENT BACTERICIDAL ACTIVITY Natalie L.

Reynolds, Martin De Cecco, Karen Taylor, Chloe Stanton, Fiona Kilanowski, Jason Kalapothakis, Emily Seo, Dusan Uhrin, Dominic Campopiano, John Govan, Derek Macmillan,...

AAC:  Mar 20 2010 2:06AM
Matching: gram positive
Find similar documents
HTML
61%
Characterization of CEM-101 Activity Against Gram-Positive Organisms [Article]
In vitro activity of CEM-101, a new fluoroketolide, was determined against Gram-positive organisms with various macrolide susceptibility profiles.

Experiments for determination of MIC and MBC, timed-killing, single-step and multistep mutation rates,...

AAC:  Mar 20 2010 2:06AM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files IND in China for Antibiotic Drug Candidate MRX-I
-- MRX-I Targets Multi-Drug Resistant Gram Positive Infections -- HAYWARD, USA and SHANGHAI, China March 15, 2010 MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that...
Pharma Live:  Mar 18 2010 5:28PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced...

Pharma Live:  Mar 18 2010 5:28PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections HAYWARD, CA, USA and SHANGHAI, CHINA | March 15, 2010 | MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that...
PipelineReview:  Mar 17 2010 3:04AM
Matching: gram positive
Find similar documents
HTML
72%
Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling
Cytolethal distending toxins (CDTs) are proteins produced and secreted by facultative pathogenic strains of Gram-negative bacteria with potentially genotoxic effects.

Mammalian cells exposed to CDTs undergo cell type-dependent cell-cycle arrest or...

Journal of Cellular and Molecular Medicine:  Mar 15 2010 7:50AM
Matching: gram bacterial
Find similar documents
HTML
61%
::: MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
- MRX-I Targets Multi-Drug Resistant Gram Positive Infections - HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced...

Biotech Intelligence:  Mar 15 2010 4:02PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
- MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics,...

Triangle Business Journal:  Mar 15 2010 1:51PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
- MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics,...

Kansas City Business Journal:  Mar 15 2010 1:48PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company...

San Francisco Business Times:  Mar 15 2010 2:24PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company...

Twin Cities Business Journal:  Mar 15 2010 1:41PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company...

Phoenix Business Journal:  Mar 15 2010 1:40PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company...

Orlando Business Journal:  Mar 15 2010 1:40PM
Matching: gram positive
Find similar documents
HTML
61%
MicuRx Pharmaceuticals Files Investigational New Drug Application for MRX-I
MRX-I Targets Multi-Drug Resistant Gram Positive Infections - PR Newswire HAYWARD, Calif.

and SHANGHAI, March 15 HAYWARD, Calif.

and SHANGHAI, March 15 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company...

Puget Sound Business Journal:  Mar 15 2010 1:40PM
Matching: gram positive
Find similar documents
HTML
72%
Anacor Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released
Refer to a friend 2010-03-10 19:07:14 - Anacor Pharmaceuticals, Inc.

- Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com Anacor Pharmaceuticals, Inc.

- Pharmaceuticals & Healthcare -...

PR inside:  Mar 10 2010 6:28PM
Matching: gram bacterial
Find similar documents
HTML
61%
PEPTIDE FRAGMENTS OF A {beta}-DEFENSIN DERIVATIVE WITH POTENT BACTERICIDAL ACTIVITY
PEPTIDE FRAGMENTS OF A -DEFENSIN DERIVATIVE WITH POTENT BACTERICIDAL ACTIVITY Natalie L.

Reynolds, Martin De Cecco, Karen Taylor, Chloe Stanton, Fiona Kilanowski, Jason Kalapothakis, Emily Seo, Dusan Uhrin, Dominic Campopiano, John Govan, Derek Macmillan,...

AAC:  Feb 24 2010 9:17AM
Matching: gram positive
Find similar documents
HTML
61%
Characterization of CEM-101 Activity Against Gram-Positive Organisms
Antimicrob.

Agents Chemother.

doi:10.1128/AAC.01662-09 Copyright (c) 2010, American Society for Microbiology and/or the Listed Authors/Institutions.

All Rights Reserved.

Leah N.

Woosley, Mariana Castanheira*, and Ronald N.

Jones JMI Laboratories,...

AAC:  Feb 24 2010 9:18AM
Matching: gram positive
Find similar documents
HTML
100%
Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin
Nailor MD et al.

Strategies to control this emergence of resistance are expected to be proposed.

Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin,...

MDLinx:  Feb 19 2010 9:51AM
Matching: gram positive bacterial
Find similar documents
HTML
72%
Xbrane Bioscience AB Acquires Rights to Innovative Protein Production System From Vaxiion Therapeutics, Inc.
STOCKHOLM & SAN DIEGO--(BUSINESS WIRE)--The Swedish biotech company Xbrane Bioscience and the San Diego based biotech company Vaxiion Therapeutics, Inc.

have announced that they have reached a licensing arrangement granting Xbrane Bioscience rights to...

Business Wire via Yahoo!:  Jan 20 2010 7:17PM
Matching: gram bacterial
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.